Market Driver Insights: The Impact of Recent Advances on the Point-of-Care Glucose Testing Market

The point-of-care glucose testing market is set for substantial expansion over the coming years, driven by advancements in technology and growing patient demand for convenient diabetes management tools. As healthcare increasingly shifts toward decentralized and personalized solutions, this market is emerging as a crucial segment within diabetes care.

Strong Market Growth Expected in Point-of-Care Glucose Testing by 2030
The point-of-care glucose testing market is forecasted to reach a value of $6.95 billion by 2030, growing at a compound annual growth rate (CAGR) of 6.3%. This upward trajectory is supported by a range of factors including the widespread adoption of connected glucose monitoring devices, enhanced integration with mobile health applications, and the rising preference for non-invasive glucose monitoring techniques. Additionally, expansion in remote patient monitoring programs and an increased focus on personalized diabetes management strategies are propelling market growth. Key trends shaping the market during this period include greater use of Bluetooth-enabled glucose meters, growing popularity of continuous glucose monitoring (CGM) devices, an increase in home-based testing solutions, the rise of comprehensive digital diabetes management platforms, and a stronger emphasis on patient-driven self-monitoring.

Download a free report of the point-of-care glucose testing market report:
https://www.thebusinessresearchcompany.com/report/point-of-care-glucose-testing-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Apr_PR

Prominent Companies Leading the Point-of-Care Glucose Testing Market
Several significant players dominate the point-of-care glucose testing industry, including F Hoffmann-La Roche Ltd., Abbott Laboratories Inc., Siemens Healthineers, TaiDoc Technology Corporation, Nipro Corporation, Dexcom Inc., LifeScan Inc., Nova Biomedical Corporation, Ypsomed AG, Ascensia Diabetes Care Holdings AG, Trividia Health Inc., Radiometer Medical ApS, HemoCue AB, EKF Diagnostics Holdings plc, Trinity Biotech plc, Bionime Corporation, PTS Diagnostics, ForaCare Inc., Menarini Diagnostics, ACON Laboratories Inc., Senseonics Holdings Inc., Prodigy Diabetes Care LLC, Nemaura Medical Inc., and Medtronic plc.

Strategic Acquisition Expands Roche's Point-of-Care Capabilities
In a significant move during August 2024, F. Hoffmann-La Roche AG, the Swiss healthcare giant, acquired Point of Care technology from UK-based LumiraDx Ltd. Although the financial details remain undisclosed, this acquisition is designed to strengthen Roche's diagnostics portfolio by incorporating a versatile platform capable of running multiple tests on a single device. This strategic addition supports Roche's goal of expanding decentralized healthcare solutions, particularly in point-of-care glucose testing. LumiraDx Ltd. specializes in point-of-care diagnostics, providing innovative glucose testing products.

View the full point-of-care glucose testing market report:
https://www.thebusinessresearchcompany.com/report/point-of-care-glucose-testing-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Apr_PR

Innovations Fueling Growth in Point-of-Care Glucose Testing
The market is witnessing rapid technological progress as leading companies focus on developing advanced wearable continuous glucose monitoring (CGM) systems embedded with predictive analytics. These innovations aim to improve real-time glucose monitoring, enhance glycemic control, and reduce the need for traditional manual testing. CGM systems function through a small sensor placed under the skin that continuously measures glucose in interstitial fluid and transmits data to a connected mobile application. This setup enables proactive diabetes management by providing real-time alerts and predicting glucose trends. For example, in July 2024, Roche launched the Accu-Chek SmartGuide CGM system, designed specifically for diabetes patients. This device delivers glucose readings every five minutes, incorporates AI-powered trend predictions up to two hours in advance, offers overnight alerts for hypo- or hyperglycemia, and connects seamlessly to a mobile app, facilitating remote monitoring and elevating patient safety and convenience compared to traditional finger-prick tests.

Detailed Market Segments in Point-of-Care Glucose Testing
The point-of-care glucose testing market report is organized into several key segments:
1) Product Types: Lancet and lancing devices, test strips, and glucose meters.
2) Testing Sites: Fingertip testing and alternate site testing.
3) Applications: Type-1 diabetes and Type-2 diabetes management.
4) End-Users: Professional diagnostic centers, hospitals and clinics, home care settings, and other users.

Within these categories, subsegments include specific classifications such as single-use lancets, multi-use lancets, and adjustable lancing devices; glucose test strips, ket*one test strips, and combination strips measuring both glucose and ket*ones; blood glucose meters, continuous glucose monitoring meters, and Bluetooth-enabled meters.

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.